Skip to content

OPEN Foundation

Menu

Therapist Training
- ADEPT
- Foundations
  - Curriculum
  - Faculty
  - Enrolment
  - FAQ
Conference
Community
Events
- Workshop: Ketamine-Assisted Psychotherapy (KAP)
Articles & News
About
- Team
- Vacancies
Contact
Donate
Member Login

Search

Articles & News

Search

Search

Scientific Discipline
Substance
Therapeutic Application

Ketamine: Future Treatment For Unresponsive Depression?

September 1, 2016

Ibogaine for treating drug dependence. What is a safe dose?

September 1, 2016

The Resurrection Of Psychedelic Psychiatry And Its Role In Addiction Treatment

September 1, 2016

Ketamine for Depression: An Update

August 24, 2016

It’s time to take psilocybin seriously as a possible treatment for substance use disorders.

August 24, 2016

It's time to take psilocybin seriously as a possible treatment for substance use disorders.

August 24, 2016

Psilocybin: panacea or placebo?

August 24, 2016

Question-based Drug Development for psilocybin – Authors’ reply

August 24, 2016

Question-based Drug Development for psilocybin – Authors' reply

August 24, 2016

Question-based Drug Development for psilocybin

August 24, 2016

OPEN is a public benefit organisation (ANBI) and registered charity with the Dutch tax authorities.

Linkedin Twitter Facebook-f Instagram Youtube

OPEN

About
Events
Programmes
Resources
Blog
Newsletter
Privacy Policy
Terms & Conditions
Klachtenregeling
Contact

ABOUT

Mission
Team
Partners
FAQs
Nonprofit Status
Financial Reports
Indegeest Network
Working Group GGZ

EVENTS

ICPR Conference
Online Events
On-site Events

RESOURCES

Talks
Papers
Books

PROGRAMMES

Membership
Training
Research

ACTIONS

Participate
Vacancies
Donate

© 2007-2024 OPEN Foundation

Placebo Effects & Blinding in Psychedelic Trials - September 8